What is WHWK's market cap?

$180.72M, based on the Nov 4 close of $3.17.

Does Whitehawk Therapeutics pay a dividend?

No regular cash dividend has been paid in the last year.

How much of WHWK is sold short?

2.6M shares, 8.7% of float, as of Oct 15, 2026.

What sector is WHWK in?

Healthcare, in the Pharmaceuticals industry.

NASDAQ · WHWKHealthcarePharmaceuticals

Whitehawk Therapeutics, Inc. Common Stock (WHWK)

$3.17+2.26%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$3.17▲ 40.27% in range

Nov 4, 2025Low $1.99 · High $5.10Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Whitehawk Therapeutics closed at $3.17 on Nov 4, up 2.26%, 37.8% below its 52-week closing high. Volume of 468.3K shares was 1.40× its 20-day average (above normal).

Split-adjusted performance: -12.2% over one month, -23.6% over six months, +42.8% over one year.

Short interest was 2.6M shares at the Oct 15 settlement, down 3.3% from the prior report (8.7% of float, 7.4 days to cover).

Market cap$180.7M57.0M shares

Revenue · quarter$0.00—

Diluted EPS$-0.20—

P/E · TTM—

Net margin—

Dividend yieldNone

52-week range1.99 – 5.10−37.8% from high

Volume468.3K1.40× 20-day avg

Volatility · 60d51.5%Annualised

Short % of float8.7%7.4 days to cover

Net cash$190.0MCash $190.0M

Next earnings—Not scheduled

Split-adjusted performance

1W −8.4%1M −12.2%3M −32.6%6M −23.6%YTD +31.0%1Y +42.8%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum53

Revenue growth—

Net margin—

Value (low P/E)—

Size47

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →

Shares short2.6M−3.3% vs prior

Days to cover7.4Settled Oct 15

% of float8.7%

Short vol. 10d45.8%of daily volume

Closest peers by size in Pharmaceuticals

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
WHWKWhitehawk Therapeutics	$3.17	+2.26%	−23.6%	—	—	—	$180.7M
BBOTBridgeBio Oncology Therapeutics	$2.30	−0.86%	−72.4%	—	—	—	$184.4M	Compare
ALXOALX Oncology Holdings	$1.36	+5.43%	−34.9%	—	—	—	$188.1M	Compare
ORMPOramed Pharmaceuticals	$4.13	+3.25%	+5.4%	—	—	1.0	$171.8M	Compare
PEPGPepGen	$2.45	−0.41%	+32.8%	—	—	—	$169.7M	Compare
AKBAAkebia Therapeutics	$0.6947	−4.28%	−53.1%	−21.4%	−18.1%	—	$192.5M	Compare
SIONSionna Therapeutics	$3.73	+2.19%	−91.4%	—	—	—	$168.6M	Compare
INOInovio Pharmaceuticals	$1.62	−2.41%	+30.6%	—	—	—	$167.5M	Compare
ZNTLZentalis Pharmaceuticals	$1.76	−1.12%	−57.9%	—	—	—	$166.6M	Compare

News about Whitehawk Therapeutics

All news →

No recent articles focused on Whitehawk Therapeutics.

Quick answers

What does Whitehawk Therapeutics do?: Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers.
What is WHWK's market cap?: $180.72M, based on the Nov 4 close of $3.17.
Does Whitehawk Therapeutics pay a dividend?: No regular cash dividend has been paid in the last year.
How much of WHWK is sold short?: 2.6M shares, 8.7% of float, as of Oct 15, 2026.
What sector is WHWK in?: Healthcare, in the Pharmaceuticals industry.

About Whitehawk Therapeutics

Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.

HQ: Morristown, NJ23 employeesListed Aug 27, 2021whitehawktx.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology